Asosiy kontentga oʻtish
Sharh maqola

Long non-coding RNAs regulate drug resistance in cancer

Kaisheng LiuThe First Affiliated Hospital of Southern University of Science and Technology, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen, 518020, Guangdong, People's Republic of ChinaLin GaoShenzhen Second People's HospitalXiaoshi MaShenzhen Second People's HospitalJuanjuan HuangDepartment of Physics, Technical University of Munich, 85748, Garching, GermanyJuan ChenShenzhen Second People's HospitalLeli ZengTomas Lindahl Nobel Laureate Laboratory, Research Centre, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, Guangdong, People's Republic of ChinaCharles R. AshbyCollege of Pharmacy and Health Sciences, St. John's University, Queens, New York, NY, 11439, USAChang ZouThe First Affiliated Hospital of Southern University of Science and Technology, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, 518020, Guangdong, People’s Republic of ChinaZhe‐Sheng ChenCollege of Pharmacy and Health Sciences, St. John's University, Queens, New York, NY, 11439, USA. [email protected]
2020en
ABI

Annotatsiya

Chemoresistance, whether intrinsic or acquired, is a major obstacle in the treatment of cancer. The resistance of cancer cells to chemotherapeutic drugs can result from various mechanisms. Over the last decade, it has been reported that 1ong noncoding RNAs (lncRNAs) can mediate carcinogenesis and drug resistance/sensitivity in cancer cells. This article reviews, in detail, recent studies regarding the roles of lncRNAs in mediating drug resistance.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba